New Clinical Practice Guidelines for Rare Cancer Treatment

New Clinical Practice Guidelines for Rare Cancer Treatment

The National Comprehensive Cancer Network® today announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Ampullary Adenocarcinoma. This evidence- and expert consensus-based resource follows the recent publication of new NCCN Guidelines® for Malignant Peritoneal Mesothelioma, bringing the total number of clinical guidelines to 83. “We know there’s a real need to share evidence-based expert recommendations for some of these rarer tumor types, which oncologists see infrequently and may not have the opportunity to keep as […]

Click here to read: eTurboNews | TravelWireNews | TravelNewsOnline

Click here to read the full article.

New Clinical Practice Guidelines for Rare Cancer Treatment

 

Source: eTurboNews

Related posts